Who are the key players in North America Neurodiagnostics Market industry?

The top five players in the North America Neurodiagnostics Market are Nihon Kohden, Natus Medical Incorporated, Medtronic plc, GE Healthcare, and Siemens Healthineers. These companies are recognized for their advanced neurodiagnostic technologies, extensive product portfolios, and strong market presence across the region, driving innovation and adoption in clinical settings.

What is the North America Neurodiagnostics Market growth?

The North America Neurodiagnostics Market has experienced steady growth, driven by the rising prevalence of neurological disorders and technological advancements. For example, in 2023, Medtronic saw increased demand for its nerve monitoring solutions, contributing to higher revenue and expanding the market’s growth trajectory.

Which segment accounted for the largest North America Neurodiagnostics Market share?

The epilepsy diagnosis segment held the largest market share in North America’s neurodiagnostics market. Advanced EEG and neuroimaging technologies, widely adopted for epilepsy detection and monitoring, have contributed to the segment’s dominance due to the region’s high awareness and increasing incidence of epilepsy cases.

What are the factors driving the North America Neurodiagnostics Market?

Key drivers include increased research and development by companies like GE Healthcare, a rise in neurological diseases, and growing adoption of minimally invasive neurodiagnostic procedures. The integration of AI and digital health tools significantly enhances diagnostic accuracy, fueling the market’s growth.

Which type accounted for the largest North America Neurodiagnostics Market share?

Electroencephalography (EEG) systems accounted for the largest share in the North America Neurodiagnostics Market. EEG systems are widely used for diagnosing epilepsy, sleep disorders, and other neurological conditions, due to their non-invasive nature, adaptability, and effectiveness, which drive their strong adoption in clinical practice.

Home Healthcare

North America Neurodiagnostics Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

Name: North America Neurodiagnostics Market
Brand: Bussiness Insights

North America Neurodiagnostics Market: by Type (Electroencephalography (EEG), Magnetoencephalography (MEG), Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron Emission Tomography (PET), Electromyography (EMG)), Application (Epilepsy, Alzheimer’s Disease, Stroke, Sleep Disorders, Parkinson's Disease, Headache Disorders), Distribution Channels (Hospitals, Diagnostic Centers, Ambulatory Care Centers, Clinics, Research Institutes, Others), Technology (Imaging, Molecular, Electrophysiology, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025

Last Updated: 31-07-2025 | Format: PDF | Report ID:20394 | Author: Raj K

RD TOC Segmentation Research Methodology Request For Free Sample

North America Neurodiagnostics Market Outlook, 2025-2035

The North America neurodiagnostics market encompasses advanced technologies and solutions aimed at the diagnosis and monitoring of neurological disorders. This market includes various tools like EEG, MEG, MRI, CT, PET, and EMG, and covers a wide application spectrum from epilepsy to Alzheimer’s disease. The region benefits from a sophisticated healthcare infrastructure and increasing prevalence of neurological conditions. Key players are driving innovation through new product launches, mergers, and AI-based diagnostic tools. The market is forecasted to experience robust growth between 2025 and 2035, propelled by rising awareness, funding, and technological advancements.

Latest Market Dynamics

Key Drivers

Rising prevalence of neurological disorders: Increasing incidences of epilepsy, Alzheimer’s, and stroke, particularly in the aging population, are fueling demand for advanced neurodiagnostic solutions. For example, Medtronic announced expanded US trials for AI-enabled diagnostics for epilepsy and Parkinson's in June 2024.

Adoption of AI and machine learning: Companies like Philips Healthcare are integrating AI in imaging solutions to automate and enhance neurological assessments, increasing diagnostic efficiency and accuracy.
Home-based and portable diagnostics: Advanced Brain Monitoring, Inc. and Lifelines Neuro Company are expanding remote and ambulatory EEG offerings, supporting decentralized and patient-friendly neurodiagnostic services.

Expansion in personalized medicine: The integration of genomics and molecular diagnostics enables tailored therapies for neurological disorders, highlighted by Siemens Healthineers’ precision neurology program launched in 2024.
Growth in telehealth: Accelerated adoption of telemedicine platforms is broadening access to neurodiagnostic evaluations, especially in rural and underserved regions. Companies like Compumedics are heavily investing in tele-neurology solutions.

Regulatory hurdles and reimbursement complexities: Despite technological advances, varied approval requirements and uncertain insurance coverage remain major obstacles. Natus Medical faces ongoing regulatory updates for its neurodiagnostic devices in North America.
Shortage of skilled professionals: There is a growing gap in the availability of trained neurodiagnostic technologists and clinicians to operate advanced devices and interpret results, as noted by Advanced Brain Monitoring, Inc.

High equipment and operational costs: The significant capital investment for MRI, MEG, and PET systems restrains smaller clinics and medium-sized facilities. Even with financing, only large networks like those partnered with Siemens Healthineers can afford upgrades routinely.
Stringent data privacy regulations: Increasingly complex data security and patient privacy requirements make compliance challenging, limiting market velocity for new solutions, which recently affected rollouts from Masimo Corporation.

The market share for neurodiagnostics by type in North America in 2025 is led by Magnetic Resonance Imaging (MRI), owing to its versatile applications and widespread adoption. Electroencephalography (EEG) continues to be critical for neurological diagnostics, while advanced imaging modalities such as PET and MEG are witnessing increased use due to their ability to detect complex disorders. The combination of technological advances and broadened reimbursement is helping MRI maintain dominance, even as electrophysiological and molecular methods experience rapid growth.

In 2025, epilepsy stands as the largest single application for neurodiagnostic tools in North America, attributable to high disease awareness, rapid diagnosis demands, and continuous advancements in electrophysiology. Alzheimer’s Disease applications closely follow, fueled by demographic shifts and ongoing therapeutic research. The balance of the market is split between stroke, sleep disorders, Parkinson’s, and headache disorders, indicating increased utility across the neurological care spectrum and underscoring the important role neurodiagnostic technologies play in both acute and chronic settings.

The revenue trajectory for the North America neurodiagnostics market indicates strong and steady growth from $2,800 Million in 2020 to an estimated $6,900 Million by 2035. This acceleration is driven by expanding healthcare budgets, increased prevalence of neurological diseases, advancements in diagnostic technologies, and strategic company partnerships. The sustained rise in revenue each year highlights robust ongoing investments from public and private sectors fueling innovation, improved accessibility, and wider application in both hospital and outpatient environments.

Year-over-year (YOY) growth in the North America neurodiagnostics market is anticipated to peak at 8.6% in 2025, gradually normalizing to 5.2% by 2035 as the market matures. The highest YOY rates are fueled by a combination of robust device launches, favorable regulatory progress, and expanding telemedicine integration. Growth rates stabilize post-2030 due to increased market penetration and consolidation, signaling a shift towards maturity after a period of fast-paced expansion.

The United States leads the neurodiagnostics market in North America, accounting for nearly three-quarters of the regional market share, followed by Canada and Mexico. This dominance is driven by the US's advanced healthcare infrastructure, robust investment in R&D, and rapid adoption of cutting-edge neurological technologies. Canada benefits from strategic partnerships and expanding government-funded initiatives, while Mexico sees growing usage in private health centers. These dynamics together foster a thriving regional neurodiagnostics ecosystem.

Market share among neurodiagnostics players is competitive, with GE Healthcare, Siemens Healthineers, and Philips Healthcare constituting the core leaders due to expansive product portfolios and strong market reach. Natus Medical and Nihon Kohden stand out in specialized areas such as electrophysiology and clinical EEG, maintaining significant presence. These leading companies continuously invest in innovation, strategic alliances, and localized support, ensuring sustained market leadership across North America.

Hospitals represent the dominant buying segment for neurodiagnostics equipment and services in North America, accounting for a majority share thanks to high patient inflow, larger budgets, and the need for integrated neurological care. Diagnostic centers and ambulatory care centers are rapidly expanding, driven by the shift towards community-based and outpatient healthcare services. Research institutes also contribute notably as investments in neurological sciences and innovation accelerate.

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	3900
Regions	US, Canada, Mexico
Segments	By Type (Electroencephalography (EEG), Magnetoencephalography (MEG), Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron Emission Tomography (PET), Electromyography (EMG)), By Application (Epilepsy, Alzheimer’s Disease, Stroke, Sleep Disorders, Parkinson's Disease, Headache Disorders), By Distribution Channels (Hospitals, Diagnostic Centers, Ambulatory Care Centers, Clinics, Research Institutes, Others), By Technology (Imaging, Molecular, Electrophysiology, Genomics, Proteomics, Others), By Organization Size (Small, Medium, Large)
Players	Nihon Kohden Corporation, Natus Medical Incorporated, Compumedics Limited, Medtronic plc, Masimo Corporation, Siemens Healthineers, GE Healthcare, Philips Healthcare, Lifelines Neuro Company, Cadwell Industries Inc., Advanced Brain Monitoring Inc., FEMTONICS, Neurosoft, Moberg ICU Solutions, Advanced Medical Electronics Corp.

June 2024: GE Healthcare launches SIGNA Experience, a new MRI platform with AI-driven neurodiagnostics capabilities.
July 2024: Philips Healthcare announces FDA clearance for IntelliSpace Neuro MR software supporting integrated neurology workflows.
August 2024: Siemens Healthineers introduces a personalized neurology diagnostics suite focused on Alzheimer’s biomarker expansion.
September 2024: Medtronic begins North American clinical trials of a novel wearable EEG device for home epilepsy monitoring.
October 2024: Compumedics expands its tele-neurology platform in Canada and US, targeting remote electrophysiology diagnostics in rural areas.

About the Author

Raj K

Senior Market Research Analyst

Raj K is a Senior Market Research Analyst specializing in market research, industry analysis, and business consulting across Healthcare. Raj K brings a commercially grounded perspective to sectors shaped by changing demand, innovation, and competitive dynamics, helping turn complex market trends into clear strategic insights for business decision-makers. With 10+ years of experience across research, analytics, and strategic advisory roles, Raj K has helped organizations translate data into actionable growth strategies.

HealthcareMarket ResearchIndustry AnalysisStrategic Consulting

Key Questions Answered

»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?

Download Sample

Why Choose Bussiness Insights?

»Strong Industry Focus
»Extensive Product Offerings
»Customer Research Services
»Robust Research Methodology
»Comprehensive Reports
»Latest Technological Developments
»Value Chain Analysis
»Potential Market Opportunities
»Growth Dynamics
»Quality Assurance
»Post-sales Support
»Regular Report Updates

Speak to Analyst

North America Neurodiagnostics Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

North America Neurodiagnostics Market Outlook, 2025-2035

Latest Market Dynamics

Key Drivers

Key Trends

Key Opportunities

Key Challenges

Key Restraints

North America Neurodiagnostics Market Share by Type, 2025

North America Neurodiagnostics Market Share by Application, 2025

North America Neurodiagnostics Market Revenue (USD Million), 2020-2035

North America Neurodiagnostics Market YOY Growth (%), 2020-2035

North America Neurodiagnostics Market Share by Region, 2025

North America Neurodiagnostics Market Players Share, 2025

North America Neurodiagnostics Market Buyers Share, 2025

Study Coverage

Key Recent Developments

Frequently Asked Questions

About the Author

Related Reports